Back to search

Article

Apigenin-Melatonin: a novel prostate cancer Radiation Sensitizer

2023-01-05

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: Radiotherapy is a common modality in prostate cancer (PrCa), with a dose of 80Gy. A higher dose of ionizing radiation is often needed to achieve an appropriate response; however, clinical evidence indicates that increasing the dose may lead to side effects. Therefore, finding a substance that sensitizes PrCa to ionizing radiation improves radiotherapy’s therapeu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
630f0e9f-16dc-5a58-bcca-f3b45ad44a86
DOI
10.21203/rs.3.rs-2395901/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Apigenin-Melatonin: a novel prostate cancer Radiation SensitizerDOI 10.21203/rs.3.rs-2395901/v1
Select a neighboring publication to make it the new centre.